1. Volume 64, Issue 4, Pages 610-621 (October 2013)
Future Direction in Pharmacotherapy for Non-neurogenic Male Lower Urinary Tract Symptoms 
Roberto Soler, Karl-Erik Andersson, Michael B. Chancellor, Christopher R. Chapple, William C. de Groat, Marcus J. Drake, Christian Gratzke, Richard Lee, Francisco Cruz 
European Urology 
Volume 64, Issue 4, Pages (October 2013)
DOI: /j.eururo
Copyright © 2013 European Association of Urology Terms and Conditions

2. Fig. 1
Pathophysiologic mechanisms and targets for pharmacotherapy for male lower urinary tract symptoms. Ach=acetylcholine; ANS=autonomic nervous system; ATP=adenosine triphosphate; CB-R=cannabinoid receptors; M3-R=M3 muscarinic receptor; NGF=nerve growth factor; NO=nitric oxide; P-R=purinergic receptors; TRP=transient receptor potential (channels); α1a-AR=α1A-adrenoreceptor; α1D-AR=α1D-adrenoreceptor; β3-AR=β3-adrenoreceptor.
European Urology  , DOI: ( /j.eururo )
Copyright © 2013 European Association of Urology Terms and Conditions